National Comprehensive Cancer Network
- NCCN
Guidelines®- End User License Agreement
- NCCN Guidelines for
Treatment of Cancer by Site- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Anal Carcinoma
- Basal and Squamous Cell Skin Cancers
- Bladder Cancer
- Bone Cancer
- Breast Cancer
- Central Nervous System Cancers
- Cervical Cancer
- Chronic Myelogenous Leukemia
- Colon Cancer
- Dermatofibrosarcoma Protuberans
- Esophageal and Esophagogastric Junction Cancers
- Gastric Cancer
- NCCN Guidelines for Detection,
Prevention, & Risk Reduction - NCCN Guidelines for
Supportive Care - NCCN Guidelines for
Age Related Recommendations - NCCN Guidelines for Patients®
- International Adaptations & Translations
- NCCN Pocket Guidelines
- NCCN Disclosure Policies &
Potential Conflicts of Interest - Licensing and Permissions
- Stay up-to-date with
NCCN Flash Updates™ - NCCN Guidelines Apps
- NCCN
Compendia- End User License Agreement
- NCCN Compendium®
- NCCN Biomarkers Compendium™
- Subscribe to the NCCN Compendia
- Licensing and Permissions
- Subscriptions
& Products- NCCN Compendium
- NCCN Biomarkers Compendium
- NCCN Templates
- Combination Subscriptions
- NCCN Flash Updates™
- NCCN Flash Updates™ Coupons
- NCCN Trends™ Surveys & Data
- NCCN Academy Video Modules
- NCCN eBulletin Newsletter
- NCCN Health Information Technology Licensees
- JNCCN — Journal of the National Comprehensive Cancer Network
- Advertising Opportunities
- NCCN Online Catalog
- Clinical & Business
Resources- Members Only
- NCCN Corporate Council
- NCCN Academy
- NCCN Insights: Analytics, Research & Consulting
- NCCN Resource Tool: REMS
- NCCN Collaboration with the National Business Group on Health
- NCCN Virtual Reimbursement Resource Room
- NCCN Health Information Technology Licensees
- NCCN Oncology Policy Program White Papers
- NCCN Oncology Research Program (ORP)
- ORP Recent News
- NCCN ORP Affiliate Research Project
- ORP Scientific Publications
- ORP Investigator Steering Committee
- ORP Testimonials
- Clinical Trials at NCCN Member Institutions
- Find ORP Funded Clinical Trials at NCCN Member Institutions
- NCCN Specialized Imaging Research Consortium™ (SIRC)
- NCCN ORP Disclosure Policy
- NCCN ORP for Industry
- NCCN Informed Consent Language Database
- NCCN Content Policies
- Patient
Resources- NCCN Guidelines for Patients®
- NCCN Website for Patients and
Caregivers - NCCN.com - Find an NCCN Member Institution
- Find an NCCN Cancer Center Near You
- Information on Patient Assistance & Reimbursement Help
- NCCN Virtual Reimbursement Resource Room Guide
- Find Clinical Trials
- NCCN Foundation
- Donate to the NCCN Foundation
NCCN Research & Business Resources
NCCN Oncology Research Program (ORP)
NCCN ORP Mission Statement
The NCCN ORP strives to improve the quality of life for patients and reduce cancer-related deaths by advancing cancer therapies through research. We believe we can achieve this goal by supporting oncology preclinical, translational, and clinical research at NCCN Member Institutions. We recognize the importance of developing and maintaining strong alliances with industry and actively facilitating collaborations between academia and industry drug developers making important scientific strides in the field of oncology. It is NCCN's vision to have the NCCN ORP become a Center for Excellence in the United States for providing outstanding research and research services.
- Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
- Read more about NCCN Member Institutions
- Download Oncology Research Program Brochure
- Learn more about the NCCN ORP Affiliate Research Project
- Read about the NCCN Specialized Imaging Research Consortium™ (SIRC)
About the NCCN Oncology Research Program
The NCCN Oncology Research Program (ORP) is organized to obtain funding to support scientifically meritorious research studies (clinical trials) at NCCN Member Institutions. Policies and standards for the program are set by the NCCN Investigator Steering Committee, comprised of senior research physicians appointed by each NCCN Member Institution. The NCCN ORP has received millions of dollars in research grants from major pharmaceutical companies to support investigator-initiated trials, which explore new venues of clinical investigation that answer important research questions. Studies evaluate innovative combinations and sequencing regimens of drugs, mechanisms of action of specific agents, drug resistance, or are directed toward exploring extended uses for specific agents.
View the NCCN ORP Press Releases
View the NCCN ORP Scientific Publications
View the NCCN Investigator Steering Committee
View the NCCN ORP Testimonials
View the NCCN ORP Disclosure Policy
Leading clinicians and investigators from NCCN Member Institutions evaluate promising new chemical entities or biological agents.
Members Only Section
NCCN Oncology Research Program (ORP) – Click here if you are a clinician at an NCCN Member Institution and would like to:
- Update your information in the Investigator Database
- View current opportunities for research grants
- View information regarding previously funded research grants
Industry Section
View information for the NCCN Oncology Research Program for Industry.
| Quick Links |
|
|
About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us
275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0280
Copyright © 2013 National Comprehensive Cancer Network, All Rights Reserved